Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedMay 28, 2026
DataAggregated Company Financials
Companies56
  • 7D1.8%
  • 3M12.7%
  • 1Y49.8%
  • YTD-1.2%

Trulieve Cannabis is up 7.6%, leading the way for the Pharma industry, which has gained 1.8%. This means that the industry has gained 50% over the past year. As for the next few years, earnings are expected to grow by 32% per annum.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 28 May 2026CA$16.1bCA$12.2b-CA$1,894,257,182.778.1x-8.5x1.3x
Sat, 25 Apr 2026CA$15.8bCA$11.2b-CA$1,666,746,960.2314.8x-9.5x1.4x
Mon, 23 Mar 2026CA$13.2bCA$11.3b-CA$1,701,194,077.0211.5x-7.7x1.2x
Wed, 18 Feb 2026CA$14.3bCA$11.2b-CA$1,898,020,108.9314.9x-7.5x1.3x
Fri, 16 Jan 2026CA$17.0bCA$11.3b-CA$1,959,031,887.0516.3x-8.7x1.5x
Sun, 14 Dec 2025CA$19.2bCA$11.2b-CA$1,911,998,737.3214.8x-10x1.7x
Tue, 11 Nov 2025CA$15.2bCA$11.3b-CA$1,876,410,918.5517.8x-8.1x1.4x
Thu, 09 Oct 2025CA$18.4bCA$11.2b-CA$2,036,511,751.4235.8x-9x1.6x
Sat, 06 Sep 2025CA$15.9bCA$11.2b-CA$2,031,100,344.4338.1x-7.8x1.4x
Mon, 04 Aug 2025CA$11.8bCA$11.8b-CA$2,580,662,352.2716.7x-4.6x1x
Wed, 02 Jul 2025CA$9.7bCA$11.7b-CA$2,515,850,664.9517x-3.8x0.8x
Fri, 30 May 2025CA$23.2bCA$11.8b-CA$2,396,620,795.0717.5x-9.7x2x
Sun, 27 Apr 2025CA$10.5bCA$11.9b-CA$2,537,137,906.5420.2x-4.1x0.9x
Tue, 25 Mar 2025CA$10.5bCA$12.3b-CA$2,567,787,653.6519.9x-4.1x0.9x
Thu, 20 Feb 2025CA$12.3bCA$12.1b-CA$2,212,835,656.1422.9x-5.5x1x
Sat, 18 Jan 2025CA$12.2bCA$12.2b-CA$2,421,943,229.6529.8x-5x1x
Mon, 16 Dec 2024CA$12.7bCA$12.0b-CA$2,588,051,717.1821.9x-4.9x1.1x
Wed, 13 Nov 2024CA$13.0bCA$11.9b-CA$2,631,380,295.5615.1x-4.9x1.1x
Fri, 11 Oct 2024CA$18.3bCA$11.7b-CA$2,697,603,068.9017.2x-6.8x1.6x
Sun, 08 Sep 2024CA$17.1bCA$11.6b-CA$2,699,993,509.6420x-6.4x1.5x
Tue, 06 Aug 2024CA$18.8bCA$11.7b-CA$3,096,658,580.3919.3x-6.1x1.6x
Thu, 04 Jul 2024CA$18.8bCA$11.7b-CA$3,225,203,624.5719.2x-5.8x1.6x
Sat, 01 Jun 2024CA$21.1bCA$11.9b-CA$3,474,747,660.6412.8x-6.1x1.8x
Mon, 29 Apr 2024CA$22.9bCA$11.8b-CA$3,444,223,192.038.4x-6.7x1.9x
Wed, 27 Mar 2024CA$23.2bCA$11.9b-CA$3,504,102,648.099.3x-6.6x2x
Fri, 23 Feb 2024CA$21.8bCA$12.0b-CA$4,642,695,320.799.4x-4.7x1.8x
Sun, 21 Jan 2024CA$20.4bCA$12.3b-CA$6,754,384,129.009.6x-3x1.6x
Tue, 19 Dec 2023CA$17.6bCA$12.3b-CA$6,738,434,260.008.2x-2.6x1.4x
Thu, 16 Nov 2023CA$17.5bCA$12.4b-CA$6,689,449,134.008.6x-2.6x1.4x
Sat, 14 Oct 2023CA$18.3bCA$12.4b-CA$7,333,238,247.0013.2x-2.5x1.5x
Mon, 11 Sep 2023CA$20.7bCA$13.0b-CA$7,922,680,059.0015.2x-2.6x1.6x
Wed, 09 Aug 2023CA$15.1bCA$13.3b-CA$9,749,939,151.0012x-1.5x1.1x
Fri, 07 Jul 2023CA$16.0bCA$13.3b-CA$9,544,539,622.0012x-1.7x1.2x
Sun, 04 Jun 2023CA$14.7bCA$13.3b-CA$10,414,249,790.0010.6x-1.4x1.1x
Price to Earnings Ratio

-1.4x


Total Market Cap: CA$14.7bTotal Earnings: -CA$10,414,249,790.00Total Revenue: CA$13.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -5.5x202420252026
Current Industry PE
  • Investors are relatively neutral on the Canadian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 3.0% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market0.67%
Healthcare0.76%
Pharma1.78%
Pharma1.78%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TRUL Trulieve CannabisCA$11.817.6%
+CA$159.6m		107.6%PS1.4x
GTII Green Thumb IndustriesCA$10.586.5%
+CA$142.4m		47.4%PE13.8x
VREO Vireo GrowthCA$0.6110.9%
+CA$83.0m		17.3%PS1.7x
WEED Canopy GrowthCA$1.494.2%
+CA$22.8m		-39.2%PS2x
CRON Cronos GroupCA$3.751.6%
+CA$22.4m		33.9%PS6.3x

Latest News

CURA
CA$4.39
Curaleaf Holdings
7D
-3.7%
1Y
259.8%
VREO
CA$0.61
Vireo Growth
7D
10.9%
1Y
17.3%
CPH
CA$16.57
Cipher Pharmaceuticals
7D
-2.1%
1Y
33.0%
Narrative Update • May 22

CPH: Share Repurchases And Higher Conviction Forecasts Will Support Future Upside

Analysts have lifted their price target on Cipher Pharmaceuticals to CA$22 from CA$21, reflecting updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E in recent research. Analyst Commentary Bullish Takeaways Bullish analysts are signaling higher conviction in Cipher Pharmaceuticals' valuation by moving the price target from CA$20 to CA$22 within recent research updates.
GUD
CA$8.05
Knight Therapeutics
7D
-1.6%
1Y
39.8%
Narrative Update • May 21

GUD: Latin American Approvals And Buybacks Will Support Future Bullish Repricing

Analysts have raised their fair value estimate for Knight Therapeutics stock from CA$11.00 to CA$12.00, citing recent price target increases and renewed coverage that highlight modest adjustments to growth and margin assumptions, along with a slightly higher future P/E multiple. Analyst Commentary Bullish analysts have recently adjusted their outlook on Knight Therapeutics, pointing to factors that they see as supportive of the higher fair value estimate.
CRON
CA$3.75
Cronos Group
7D
1.6%
1Y
33.9%
WEED
CA$1.49
Canopy Growth
7D
4.2%
1Y
-39.2%
VRNO
CA$1.54
Verano Holdings
7D
2.7%
1Y
65.6%
OGI
CA$1.56
Organigram Global
7D
4.7%
1Y
-16.6%
GTII
CA$10.58
Green Thumb Industries
7D
6.5%
1Y
47.4%
TSND
CA$0.94
TerrAscend
7D
5.6%
1Y
74.1%
TRUL
CA$11.81
Trulieve Cannabis
7D
7.6%
1Y
107.6%
LOBE
CA$0.11
Lobe Sciences
7D
-18.5%
1Y
340.0%
MVMD
CA$0.06
Mountain Valley MD Holdings
7D
-25.0%
1Y
140.0%
INNO
CA$3.17
InnoCan Pharma
7D
-36.6%
1Y
-69.5%
NTLX
CA$0.18
Neurothera Labs
7D
-30.8%
1Y
n/a
PCLO
CA$0.07
PharmaCielo
7D
-30.0%
1Y
55.6%